Tommaso Porcelli

12PUBLICATIONS
14CO-AUTHORS
Infant and child healthHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 01, 2025
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients.

Tommaso Porcelli, Cristina Luongo, Anna Cerbone

|Jan 22, 2025
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?

Tommaso Porcelli, Cristina Luongo, Anna Cerbone

|Aug 03, 2023
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.

Tommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano

|Mar 06, 2023
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence.

Maria Angela De Stefano, Tommaso Porcelli, Raffaele Ambrosio

Pageof 2